Sort   by:  
 Page size 
UnknownCo-designing person-centred quality indicator implementation for primary care in Alberta: a consensus study.
Not available
S-EPMC9641306 | biostudies-literature
UnknownGlobal Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.
Not available
S-EPMC8066045 | biostudies-literature
UnknownPatient Factors Associated With Appendectomy Within 30 Days of Initiating Antibiotic Treatment for Appendicitis.
Not available
S-EPMC8756360 | biostudies-literature
UnknownMethylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
Not available
S-EPMC6162272 | biostudies-literature
UnknownBRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Not available
S-EPMC11299415 | biostudies-literature
UnknownDe novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
Not available
S-EPMC7118694 | biostudies-literature
UnknownEffect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132 | biostudies-literature
UnknownEffect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.
Not available
S-EPMC6891239 | biostudies-literature
UnknownSimvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839 | biostudies-literature
UnknownEffect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC10326520 | biostudies-literature
Sort   by:  
 Page size